For example, for the model of the abdominal metastasis of colon cancer, the administration of OXP can increase cancer infiltration and activation of CD8+ T cells, reduce cancer CD11b+F4/80high macrophages, and reduce spleen MDSCs, thus affecting the cancer immune microenvironment [125]. The gene discussed is CD8A; the disease is cancer.